Loading
DI
Dermira, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Bald Eagle Acquisition Corp, was filed 20 Feb 2020.
Dermira, Inc.: what insiders have been doing
Dermira, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Dermira, Inc. in twelve months, the latest record being from 24 February 2020.
Our records for Dermira, Inc. go back to 2016, with 8 purchases and 126 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
355
Thresholds
n/a
Buy Volume
€711M
8 ops. · all time
Sell Volume
€11M
126 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Revenue37.7M
Net income-197.5M-523.3% margin
Last declaration on 24 February 2020
Declarations355 total
41,951 shares@ US$18.7596.7% of flowCommon StockSEC:0001562180-20-001627:0
6,000 shares@ US$18.750.2% of flowCommon StockSEC:0001562180-20-001620:0
3,441,075 shares@ US$18.7597.1% of flowCommon StockSEC:0001562180-20-001620:1
65,572 shares@ US$18.751.9% of flowCommon StockSEC:0001562180-20-001620:2
30,000 shares@ US$18.750.8% of flowCommon StockSEC:0001562180-20-001620:3
30,089 shares@ US$18.75100.0% of flowCommon StockSEC:0001562180-20-001623:0
6,000 shares@ US$18.75100.0% of flowCommon StockSEC:0001562180-20-001615:0
21,400 shares@ US$18.75100.0% of flowCommon StockSEC:0001562180-20-001622:0
5,051 shares@ US$18.7542.1% of flowCommon StockSEC:0001562180-20-001625:0
18,233 shares@ US$18.7559.6% of flowCommon StockSEC:0001562180-20-001613:0
6,000 shares@ US$18.75100.0% of flowCommon StockSEC:0001562180-20-001626:0
67,242 shares@ US$18.7598.7% of flowCommon StockSEC:0001562180-20-001612:0
6,000 shares@ US$18.75100.0% of flowCommon StockSEC:0001562180-20-001617:0
180,985 shares@ US$18.7564.9% of flowCommon StockSEC:0001562180-20-001616:2
25,401 shares@ US$18.7597.5% of flowCommon StockSEC:0001562180-20-001624:0
3,726 shares@ US$18.7512.8% of flowCommon StockSEC:0001562180-20-001621:2
16,206 shares@ US$18.7555.7% of flowCommon StockSEC:0001562180-20-001621:3
35,682 shares@ US$18.75100.0% of flowCommon StockSEC:0001562180-20-001614:0
27,000 shares0Common StockSEC:0001562180-20-001616:0
12,924 shares0Common StockSEC:0001562180-20-001621:0
10,772 shares0Common StockSEC:0001562180-20-001621:1
49,963 shares@ US$18.7517.9% of flowCommon StockSEC:0001562180-20-001616:1
6,000 shares@ US$18.75100.0% of flowCommon StockSEC:0001562180-20-001638:0
40,926,025 shares@ US$18.75100.0% of flowCommon StockSEC:0000899243-20-005280:0
Canonical exit: 20 May 2020 (T+90)
3,000 shares@ US$15.0015.8% of flowCommon StockSEC:0001562180-19-006267:0
25 of 355 declarations
About Dermira, Inc.
Dermira, Inc. is a biopharmaceutical company focused on developing treatments for skin diseases. It is listed on the XNAS market.
